Stock listing

Cartesian Therapeutics, Inc.

Selected listing: A407YS · LS · EUR · DE

Cartesian Therapeutics, Inc. (Lang & Schwarz: A407YS), Health Technology. Latest release Oct 2, 2026: Cartesian Therapeutics Announces New Employment…

A407YS:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A407YS
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Cartesian Therapeutics, Inc.

Cartesian Therapeutics Announces New Employment Inducement Grants

October 1, 2026

Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis

September 28, 2026

Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis

September 29, 2026

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 6, 2026

Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases

June 8, 2026

All Cartesian Therapeutics, Inc. news →

Events

Replays

Selecta Biosciences, Inc. (SELB) Q2 2023 Earnings Call
Thu, Aug 17, 2023 · 08:30 AM ET
Watch
Selecta Biosciences, Inc. (SELB) Q1 2023 Earnings Call
Thu, May 04, 2023 · 08:30 AM ET
Watch
Selecta Biosciences, Inc. (SELB) Q3 2022 Earnings Call
Thu, Nov 03, 2022 · 08:30 AM ET
Watch

Research Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc. company profile

View the public company page for Cartesian Therapeutics, Inc. on 6ix.

Cartesian Therapeutics, Inc. news

Read company news and market updates connected to Cartesian Therapeutics, Inc..

Cartesian Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Cartesian Therapeutics, Inc..